Abstract
IntroductionThe first drug selected for treatment of gastro-oesophageal reflux disease (GERD) and prevention of the recurrence is a proton pump inhibitor (PPI), but recently, a potassium-competitive acid blocker (P-CAB) was...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have